Buscar
PainReform Ltd
PRFXAñadir a la lista de seguimiento
1.360USD
0.0000.00%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
225.93KCap. mercado
PérdidaP/E TTM
Más Datos de PainReform Ltd Compañía
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
Información de PainReform Ltd
Símbolo de cotizaciónPRFX
Nombre de la empresaPainReform Ltd
Fecha de salida a bolsaSep 01, 2020
Director ejecutivoHadar (Ilan)
Número de empleados2
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 01
Dirección65 Yigal Alon St.
CiudadTEL AVIV-YAFO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal6744316
Teléfono97237177051
Sitio Webhttps://painreform.com/
Símbolo de cotizaciónPRFX
Fecha de salida a bolsaSep 01, 2020
Director ejecutivoHadar (Ilan)
Ejecutivos de PainReform Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ilan Hadar
Mr. Ilan Hadar
Chief Executive Officer, Chief Financial Officer
Chief Executive Officer, Chief Financial Officer
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Sigal Aviel
Dr. Sigal Aviel
Chief Operating Officer
Chief Operating Officer
--
--
Mrs. Rita Keynan
Mrs. Rita Keynan
Vice President - Pharmaceutical Operations
Vice President - Pharmaceutical Operations
--
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Efi Cohen-Arazi
Mr. Efi Cohen-Arazi
Independent Director
Independent Director
--
--
Dr. Ellen S. Baron
Dr. Ellen S. Baron
Independent Director
Independent Director
--
--
Mr. Augustine J. (Gus) Lawlor
Mr. Augustine J. (Gus) Lawlor
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ilan Hadar
Mr. Ilan Hadar
Chief Executive Officer, Chief Financial Officer
Chief Executive Officer, Chief Financial Officer
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Sigal Aviel
Dr. Sigal Aviel
Chief Operating Officer
Chief Operating Officer
--
--
Mrs. Rita Keynan
Mrs. Rita Keynan
Vice President - Pharmaceutical Operations
Vice President - Pharmaceutical Operations
--
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Efi Cohen-Arazi
Mr. Efi Cohen-Arazi
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de PainReform Ltd?
Los cinco principales accionistas de PainReform Ltd son: Mr. Ilan Hadar
¿Cuántas instituciones poseen acciones de PainReform Ltd (PRFX)?
A fecha de 2026Q1, 16 instituciones poseen acciones de PainReform Ltd, con un valor de mercado combinado de aproximadamente 15.73K, lo que representa el 1.84% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -4772.00.